Edition:
United States

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

11.74USD
4:00pm EDT
Change (% chg)

$-0.64 (-5.17%)
Prev Close
$12.38
Open
$12.18
Day's High
$12.22
Day's Low
$11.73
Volume
118,305
Avg. Vol
134,966
52-wk High
$14.62
52-wk Low
$4.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 8.20 -0.037
FY 2017 Dec '17 4.27 -0.049
Sep '17 27.18 -0.002
Jun '17 3.52 -0.036
Mar '17 2.86 -0.051
FY 2016 Dec '16 8.54 -0.036
Sep '16 2.42 -0.044
Jun '16 0.33 -0.052
Mar '16 2.92 -0.037
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 6 8.79 13.00 4.00 5.34
Quarter Ending Sep-18 6 24.88 60.00 5.00 5.34
Year Ending Dec-18 6 49.45 76.00 31.20 26.23
Year Ending Dec-19 6 25.50 65.00 0.00 22.34
Earnings (per share)
Quarter Ending Jun-18 5 -0.27 -0.24 -0.30 -0.29
Quarter Ending Sep-18 5 -0.07 0.29 -0.32 -0.29
Year Ending Dec-18 5 -0.84 -0.46 -1.12 -1.09
Year Ending Dec-19 5 -1.21 -0.93 -1.58 -1.31
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 241.68 34.14
P/E High - Last 5 Yrs. -- 292.11 47.66
P/E Low - Last 5 Yrs. -- 101.47 25.16
Beta -- 0.73 0.78
Price to Sales (TTM) 27.28 277.62 8.57
Price to Book (MRQ) 6.09 23.87 4.34
Price to Tangible Book (MRQ) 6.20 31.36 6.03
Price to Cash Flow (TTM) -- 141.06 22.77
% Owned Institutions 67.16 10.76 2.40

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 2.24 -6.55
Payout Ratio(TTM) -- 42.12 39.30

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 186.87 24.41 5.00
Sales (TTM) vs TTM 1 Yr. Ago 205.38 137.83 12.49
Sales - 5 Yr. Growth Rate -- 30.90 7.91
EPS (MRQ) vs Qtr. 1 Yr. Ago 26.19 -77.62 40.62
EPS (TTM) vs TTM 1 Yr. Ago 32.16 -- --
EPS - 5 Yr. Growth Rate -- 48.46 8.03
Capital Spending - 5 Yr. Growth Rate -- 36.24 7.42

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.67 2.56
Current Ratio (MRQ) 3.77 6.36 3.64
LT Debt to Equity (MRQ) 0.00 20.82 12.92
Total Debt to Equity (MRQ) 0.00 25.13 17.37
Interest Coverage (TTM) -- -141.93 35.98

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.43 54.96
Gross Margin - 5 Yr. Avg. -- 54.95 52.86
EBITD Margin (TTM) -187.44 -- --
EBITD - 5 Yr. Avg -- -171.02 15.70
Operating Margin (TTM) -201.94 -947.27 -0.77
Operating Margin - 5 Yr. Avg. -- -184.72 10.94
Pre-Tax Margin (TTM) -160.03 -830.61 1.31
Pre-Tax Margin - 5 Yr. Avg. -- -188.11 11.12
Net Profit Margin (TTM) -160.83 -823.71 -1.98
Net Profit Margin - 5 Yr. Avg. -- -186.54 7.48
Effective Tax Rate (TTM) -- 15.15 29.95
Effective Tax Rate - 5 Yr. Avg. -- 19.20 24.12

Efficiency

  Company industry sector
Revenue/Employee (TTM) 116,367 21,782,551 736,570,410
Net Income/Employee (TTM) -187,154 -431,793 85,786,139
Receivable Turnover (TTM) 16.74 18.21 6.05
Inventory Turnover (TTM) -- 2.86 3.65
Asset Turnover (TTM) 0.17 0.48 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -27.07 -4.01 10.37
Return on Assets - 5 Yr. Avg. -- -1.12 11.08
Return on Investment (TTM) -32.35 -5.91 13.17
Return on Investment - 5 Yr. Avg. -- 1.60 14.39
Return on Equity (TTM) -34.75 -7.75 15.14
Return on Equity - 5 Yr. Avg. -- -3.78 15.73
  1 Year 3 Year 5 Year
Sales % 166.47 -- --
EPS (TTM) % 21.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Adaptimmune Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.56 0.07 62 76
13 Week 11.93 9.48 70 28
26 Week 72.66 67.46 88 83
52 Week 170.90 137.63 90 85
YTD 85.33 78.64 90 80
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.16%
# of Holders: 89
Total Shares Held: 63,225,429
3 Mo. Net Change: 4,108,667
# New Positions: 21
# Closed Positions: 12
# Increased Positions: 47
# Reduced Positions: 33
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.